A New Suggestion for a Test Method to Increase the Reliability of Lateral Spread Response in Microvascular Decompression in Patients with Hemi-Facial Spasm
Not Applicable
Completed
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0007866
- Lead Sponsor
- Konkuk University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
We enrolled patients who underwent MVD for HFS at our institution between June 2021 and March 2022.
Exclusion Criteria
The exclusion criteria were as follows: age <19 years at the time of surgery, history of facial palsy or injections of botulinum toxin within 6 months prior to enrollment, history of MVD or related treatments, secondary HFS due to the presence of an intracranial mass or cyst (as confirmed by brain imaging), underlying diabetes mellitus or amyloidosis causing severe peripheral neuropathy, history of stroke with motor weakness or myoatrophy, neuromuscular junction disease (such as myasthenia gravis), and pregnancy.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method latency of lateral spread response
- Secondary Outcome Measures
Name Time Method Findings of lateral spreading artifact